4//SEC Filing
GREENWAY MEDICAL TECHNOLOGIES INC 4
Accession 0001573700-13-000028
CIK 0001080747operating
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 3:54 PM ET
Size
10.1 KB
Accession
0001573700-13-000028
Insider Transaction Report
Form 4
Pamlico Capital GP II LLC
10% Owner
Transactions
- Disposition from Tender
Common Stock
2013-11-04$20.35/sh−5,284,679$107,543,218→ 0 total(indirect: See footnotes) - Disposition from Tender
Stock Option (right to buy)
2013-11-04$13.43/sh−10,000$134,300→ 0 totalExercise: $6.92Exp: 2020-10-18→ Common Stock (10,000 underlying)
Pamlico Capital II, L.P.
10% Owner
Transactions
- Disposition from Tender
Common Stock
2013-11-04$20.35/sh−5,284,679$107,543,218→ 0 total(indirect: See footnotes) - Disposition from Tender
Stock Option (right to buy)
2013-11-04$13.43/sh−10,000$134,300→ 0 totalExercise: $6.92Exp: 2020-10-18→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]The sole general partner of Pamlico Capital II, L.P. is Pamlico Capital GP II LLC (together with Pamlico Capital II, L.P., the "Reporting Persons"). The managing members of Pamlico Capital GP II are Scott B. Perper, L. Watts Hamrick, III and Frederick W. Eubank, II and all matters relating to the voting or disposition of the shares beneficially owned by Pamlico Capital II, L.P. require the approval of a majority of such managing members. Scott B. Perper, L. Watts Hamrick, III and Frederick W. Eubank, II each disclaim beneficial ownership of the shares beneficially owned by Pamlico Capital II, L.P.
- [F2]Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein.
- [F3]This option was granted to D. Neal Morrison, a director of the Issuer and member of the Reporting Person. Pursuant to certain legal agreements with the Reporting Person, Mr. Morrison is deemed to hold the option for the benefit of the Reporting Person and its affiliates and may exercise the option only upon the direction of the Reporting Person. This option, which is fully vested, was canceled in the merger in exchange for a cash payment of $134,300, representing the difference between the exercise price of the option and $20.35 per share of the underlying Greenway Medical Technologies, Inc. common stock.
Documents
Issuer
GREENWAY MEDICAL TECHNOLOGIES INC
CIK 0001080747
Entity typeoperating
Related Parties
1- filerCIK 0001080747
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 3:54 PM ET
- Size
- 10.1 KB